Is CeriBell, Inc (CBLL) overvalued? · rev $65.4M
CeriBell, Inc (CBLL) is a medical devices company listed on US.
This page asks whether CeriBell, Inc (CBLL) looks expensive on cached numbers — not a short thesis.
Latest reported CBLL revenue for 2024-12-31 was $65.4M. Net income was -$40.5M. Revenue was up 44.7% from 2023-12-31 to 2024-12-31. CBLL currently screens at market cap $768.1M.
CBLL currently screens at market cap $768.1M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CBLL 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CBLL stock page for the full model, not this heading.
Not investment advice.